H.R. 172 · 117th Congress

United States Anti-Doping Agency Reauthorization Act of 2021

Introduced on Jan 4, 2021 by Mike Thompson (D-CA-5). 2 cosponsors, 1 of them from another party. Latest action (Apr 15, 2021): Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

Stage
Passed one chamber
Introduced
Jan 4, 2021
Cosponsors
2
1 from the other party
Policy area
Sports and Recreation
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To reauthorize the United States Anti-Doping Agency, and for other purposes.

Subjects

  • Alternative dispute resolution, mediation, arbitration
  • Athletes
  • Child health
  • Congressional oversight
  • Criminal investigation, prosecution, interrogation
  • Drug safety, medical device, and laboratory regulation
  • Drug, alcohol, tobacco use
  • Due process and equal protection
  • International law and treaties
  • International organizations and cooperation
  • Medical tests and diagnostic methods
  • Olympic games

Summary

By the Congressional Research Service (Passed House, Apr 14, 2021). Public domain.

United States Anti-Doping Agency Reauthorization Act of 2021

This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030.

The bill adds requirements that USADA

  • be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and
  • promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports.

The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection.

The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Mike ThompsonD-CA-5Sponsor

Democrats · 1

Republicans · 1

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

  1. On Motion to Suspend the Rules and Pass
    Apr 14, 2021· House· Passage· Passed 381–37

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Jan 4, 2021Introduced in House
  2. Jan 4, 2021Introduced in House
  3. Jan 4, 2021 · HouseReferred to the House Committee on Energy and Commerce.
  4. Feb 2, 2021 · HouseReferred to the Subcommittee on Health.
  5. Apr 14, 2021 · HouseMr. Pallone moved to suspend the rules and pass the bill.
  6. Apr 14, 2021 · HouseConsidered under suspension of the rules. (consideration: CR H1748-1750)
  7. Apr 14, 2021 · HouseDEBATE - The House proceeded with forty minutes of debate on H.R. 172.
  8. Apr 14, 2021 · HouseAt the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  9. Apr 14, 2021 · HouseConsidered as unfinished business. (consideration: CR H1781-1782)
  10. Apr 14, 2021Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99).(text: CR H1748)House · Roll call 99
  11. Apr 14, 2021 · HouseOn motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99). (text: CR H1748)House · Roll call 99
  12. Apr 14, 2021 · HouseMotion to reconsider laid on the table Agreed to without objection.
  13. Apr 15, 2021 · SenateReceived in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 5, 2026 · loaded Oct 5, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.